BPC Latest Updates

Terrain Minerals (ASX:TMX)

Inside Terrain’s Next Phase

OCT 2026

The discussion covers current capital market conditions for junior explorers, Terrain’s recent rights issue and investment from Gandel Metals, the company’s 86-hole, 10,905m RC drilling program at Smokebush, and the emerging tungsten opportunity across the project.

Austral Resources (ASX: AR1): Meeting the Next Copper Titan

Austral Resources (ASX: AR1) is a copper-focused producer and developer operating in the established Mt Isa-Cloncurry mining district of Northwest Queensland.

Brookside Energy (ASX:BRK) Announcement: First sales established from Suttles Wells

Brookside Energy is a step closer to turning its Suttles development into new production and revenue. Explore Brookside’s operations, management interviews and research through BPC’s Investor Showcase

All Your Investments On One Platform

Consolidate all your investments into one easy-to-use platform. With 24/7 access from any device, you can monitor your portfolio in real-time.

Book a complimentary portfolio review today and experience the BPC Wealth Management Investor Portal—your gateway to smarter investing. 

Subscribe to
Client Chairman's Lists

Join the Chairman’s List for timely company updates, strategic insights and direct access to key developments as they unfold. Designed for investors who value informed, considered access.

BPC Wealth Management

Portfolio Review

As part of our Wealth Management offering, we invite you to access a complimentary portfolio review with our experienced advisory team. This review is designed to provide a considered assessment of your current portfolio positioning, risk exposure and broader investment strategy, helping you identify whether your investments remain aligned with your objectives in the current market environment.

Luke brings ~15 years of experience across equity markets, including a background as an equity analyst and portfolio manager, with a focus on investment strategy, portfolio construction and small to micro-cap opportunities.

A clearer portfolio starts with a timely review

BPC Sector Spotlight Series

Sector Spotlight Series

BPC’s Sector Spotlight Series explores a different market sector each month, bringing together industry experts to share their perspectives on the trends, challenges and opportunities shaping it.

Each session is designed to give investors direct access to informed sector commentary and a clearer understanding of the forces influencing the market.

Inside perspectives on the sectors moving into focus.

Athlete's Journey

Introducing “Athlete’s Journey – Winning On & Off The Field” a special podcast series looking at the financial journey of athletes through the eyes of some of Australia’s most influential sporting figures.

BPC at RIU 2026

BPC at RIU

BPC engages with a range of companies across the resources sector at the RIU Conference, recording interviews and capturing what’s driving the market. We’ll be sharing key takeaways, the themes we’re hearing on the ground, and highlights from our RIU conversations. Want a deeper dive on the companies we’ve interviewed?

As Barclay Sees It with BPC

Cash, Australian Equities or Property? A Six-Month Outlook for High-Net-Worth Investors

This week on As Barclay Sees It, we look at a question facing many high-net-worth investors: where does new capital add the most value over the next six months?

BPC Research & Insights

BPC Research

Explore in-depth research and insights from BPC’s Research Department. Our reports focus on specific industries and companies, providing valuable analysis for investors of all levels. Each report highlights key trends, opportunities and profiles of companies within the sector, offering a comprehensive view to help guide investment decisions.

LTR Pharma: Partnerships Secure. US Commercialisation Begins

RESEARCH UPDATE

LTR Pharma: Partnerships Secure. US Commercialisation Begins

LTR Pharma (ASX: LTP) is a commercial stage pharmaceutical company focused on repurposing established therapeutics to address unmet medical needs. By leveraging proven active ingredients alongside differentiated delivery technologies, the company aims to develop therapies that offer faster onset, improved patient experience, and enhanced clinical utility.

Research built for clarity

Scroll to Top